Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Vlad Horia Schitcu, Lajos Raduly, Andreea Nutu, Oana Zanoaga, Cristina Ciocan, Vlad Cristian Munteanu, Roxana Cojocneanu, Bogdan Petrut, Ioan Coman, Cornelia Braicu & Ioana Berindan-Neagoe. (2022) MicroRNA Dysregulation in Prostate Cancer. Pharmacogenomics and Personalized Medicine 15, pages 177-193.
Read now
Read now
Gerhard Hamilton & Maryana Teufelsbauer. (2022) Adipose-derived stromal/stem cells and extracellular vesicles for cancer therapy. Expert Opinion on Biological Therapy 22:1, pages 67-78.
Read now
Read now
Alexandra Traila, Delia Dima, Patriciu Achimas-Cadariu & Romeo Micu. (2018) Fertility preservation in Hodgkin’s lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era. Cancer Management and Research 10, pages 1517-1526.
Read now
Read now
Diana Gulei, Bogdan Petrut, Adrian Bogdan Tigu, Anca Onaciu, Eva Fischer-Fodor, Atanas G. Atanasov, Calin Ionescu & Ioana Berindan-Neagoe. (2018) Exosomes at a glance – common nominators for cancer hallmarks and novel diagnosis tools. Critical Reviews in Biochemistry and Molecular Biology 53:5, pages 564-577.
Read now
Read now
Ancuta Jurj, Cornelia Braicu, Laura-Ancuta Pop, Ciprian Tomuleasa, Claudia Diana Gherman & Ioana Berindan-Neagoe. (2017) The new era of nanotechnology, an alternative to change cancer treatment. Drug Design, Development and Therapy 11, pages 2871-2890.
Read now
Read now
Cristian Berce, Ciprian Lucan, Bobe Petrushev, Sanda Boca, Mirela Miclean, Orsolya Sarpataki, Simion Astilean, Anca Buzoianu, Ciprian Tomuleasa & Anca Bojan. (2016) In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice. International Journal of Nanomedicine 11, pages 4261-4273.
Read now
Read now
Elena López-Miranda & Javier Cortés. (2016) Etirinotecan pegol for the treatment of breast cancer. Expert Opinion on Pharmacotherapy 17:5, pages 727-734.
Read now
Read now
Articles from other publishers (12)
Constantin Busuioc, Andreea Nutu, Cornelia Braicu, Oana Zanoaga, Monica Trif & Ioana Berindan-Neagoe. (2022) Analysis of Differentially Expressed Genes, MMP3 and TESC, and Their Potential Value in Molecular Pathways in Colon Adenocarcinoma: A Bioinformatics Approach. BioMedInformatics 2:3, pages 474-491.
Crossref
Crossref
Rodrigo dos A. Miguel, Amanda S. Hirata, Paula C. Jimenez, Luciana B. Lopes & Leticia V. Costa-Lotufo. (2022) Beyond Formulation: Contributions of Nanotechnology for Translation of Anticancer Natural Products into New Drugs. Pharmaceutics 14:8, pages 1722.
Crossref
Crossref
Adriana Ioana Gaia‑Oltean, Cornelia Braicu, Diana Gulei, Razvan Ciortea, Dan Mihu, Horace Roman, Alexandru Irimie & Ioana Berindan‑Neagoe. (2021) Ovarian endometriosis, a precursor of ovarian cancer: Histological aspects, gene expression and microRNA alterations (Review). Experimental and Therapeutic Medicine 21:3.
Crossref
Crossref
Raluca Munteanu, Anca Onaciu, Cristian Moldovan, Alina-Andreea Zimta, Diana Gulei, Angelo Paradiso, Vladimir Lazar & Ioana Berindan-Neagoe. (2020) Adipocyte-Based Cell Therapy in Oncology: The Role of Cancer-Associated Adipocytes and Their Reinterpretation as Delivery Platforms. Pharmaceutics 12:5, pages 402.
Crossref
Crossref
Roxana Cojocneanu, Cornelia Braicu, Lajos Raduly, Ancuta Jurj, Oana Zanoaga, Lorand Magdo, Alexandru Irimie, Mihai-Stefan Muresan, Calin Ionescu, Mircea Grigorescu & Ioana Berindan-Neagoe. (2020) Plasma and Tissue Specific miRNA Expression Pattern and Functional Analysis Associated to Colorectal Cancer Patients. Cancers 12:4, pages 843.
Crossref
Crossref
Ancuta Jurj, Oana Zanoaga, Cornelia Braicu, Vladimir Lazar, Ciprian Tomuleasa, Alexandru Irimie & Ioana Berindan-Neagoe. (2020) A Comprehensive Picture of Extracellular Vesicles and Their Contents. Molecular Transfer to Cancer Cells. Cancers 12:2, pages 298.
Crossref
Crossref
Alina-Andreea Zimta, Diana Cenariu, Alexandru Irimie, Lorand Magdo, Seyed Mohammad Nabavi, Atanas G. Atanasov & Ioana Berindan-Neagoe. (2019) The Role of Nrf2 Activity in Cancer Development and Progression. Cancers 11:11, pages 1755.
Crossref
Crossref
Zimta, Tigu, Muntean, Cenariu, Slaby & Berindan-Neagoe. (2019) Molecular Links between Central Obesity and Breast Cancer. International Journal of Molecular Sciences 20:21, pages 5364.
Crossref
Crossref
Anca Onaciu, Cornelia Braicu, Alina-Andreea Zimta, Alin Moldovan, Rares Stiufiuc, Mihail Buse, Cristina Ciocan, Smaranda Buduru & Ioana Berindan-Neagoe. (2019) Gold nanorods: from anisotropy to opportunity. An evolution update. Nanomedicine 14:9, pages 1203-1226.
Crossref
Crossref
Cornelia Braicu, Lajos Raduly, Gabriela Morar-Bolba, Roxana Cojocneanu, Ancuta Jurj, Laura-Ancuta Pop, Valentina Pileczki, Cristina Ciocan, Alin Moldovan, Alexandru Irimie, Alexandru Eniu, Patriciu Achimas-Cadariu, Angelo Paradiso & Ioana Berindan-Neagoe. (2018) Aberrant miRNAs expressed in HER-2 negative breast cancers patient. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Liren Qian, Delia Dima, Cristian Berce, Yu Liu, Ioana Rus, Lajos-Zsolt Raduly, Yi Liu, Bobe Petrushev, Ioana Berindan-Neagoe, Alexandru Irimie, Alina Tanase, Ancuta Jurj, Jianliang Shen & Ciprian Tomuleasa. (2017) Protein dysregulation in graft versus host disease. Oncotarget 9:1, pages 1483-1491.
Crossref
Crossref
Leopoldo Sitia, Raffaele Ferrari, Martina B. Violatto, Laura Talamini, Luca Dragoni, Claudio Colombo, Laura Colombo, Monica Lupi, Paolo Ubezio, Maurizio D’Incalci, Massimo Morbidelli, Mario Salmona, Davide Moscatelli & Paolo Bigini. (2016) Fate of PLA and PCL-Based Polymeric Nanocarriers in Cellular and Animal Models of Triple-Negative Breast Cancer. Biomacromolecules 17:3, pages 744-755.
Crossref
Crossref